U.S. Food and Drug Administration (FDA) placed a Boxed Warning for added risk of death from gout medication Uloric (febuxostat)

U.S. Food and Drug Administration (FDA) placed a Boxed Warning for added risk of death from gout medication Uloric (febuxostat)

conduct a large postmarket safety clinical trial. The trial was conducted in more than 6,000 patients with gout treated with either Uloric or allopurinol. The main result was a combination of heart-related death, non-deadly heart attack, non-deadly stroke, and an issue of insufficient blood supply to the heart requiring intervention, called unstable angina.

 

Does Your Issue Qualify for a Lawsuit Against the Manufacturers of Uloric? According to uloric lawsuit required by the FDA, use of Uloric may increase the chances of suffering one of the following conditions:

 

Death

 

Heart Attack

 

Stroke

 

Pulmonary Embolism (PE)

 

Deep Vein Thrombosis (DVT)

 

If you or a loved one has suffered any of the above while taking Uloric for the treatment of gout, you might be entitled to a settlement from Takeda Pharmaceuticals, as well as for any expenses, emotional distress, and inconveniences that you have endured as a result of your medical treatment.

 

The attorneys at The Meneo Law Group not only have the ability, experience, and expertise to represent your Uloric lawsuit, but a proven history of success in representing people, like you, who have been harmed by dangerous medications and products.

Iscriviti alla newsletter

Copyright © 2013 Pubblicenter.it. All rights reserved S.I.C.I. S.r.l. - P.Iva: 01484460611

Scroll to top